Home LiteratureArticle Details
PMID: 20463401 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Mitochondrial iron metabolism and its role in neurodegeneration.

Journal of Alzheimer's disease : JAD ·Vol. 20 Suppl 2 ·2010-00-00 ·Pages S551-68

Horowitz MP, Greenamyre JT

Abstract

In addition to their well-established role in providing the cell with ATP, mitochondria are the source of iron-sulfur clusters (ISCs) and heme - prosthetic groups that are utilized by proteins throughout the cell in various critical processes. The post-transcriptional system that mammalian cells use to regulate intracellular iron homeostasis depends, in part, upon the synthesis of ISCs in mitochondria. Thus, proper mitochondrial function is crucial to cellular iron homeostasis. Many neurodegenerative diseases are marked by mitochondrial impairment, brain iron accumulation, and oxidative stress - pathologies that are inter-related. This review discusses the physiological role that mitochondria play in cellular iron homeostasis and, in so doing, attempts to clarify how mitochondrial dysfunction may initiate and/or contribute to iron dysregulation in the context of neurodegenerative disease. We review what is currently known about the entry of iron into mitochondria, the ways in which iron is utilized therein, and how mitochondria are integrated into the system of iron homeostasis in mammalian cells. Lastly, we turn to recent advances in our understanding of iron dysregulation in two neurodegenerative diseases (Alzheimer's disease and Parkinson's disease), and discuss the use of iron chelation as a potential therapeutic approach to neurodegenerative disease.

MeSH Terms
Adenosine Triphosphate/metabolism Animals Homeostasis Humans Iron/metabolism Iron-Regulatory Proteins/metabolism Iron-Sulfur Proteins/metabolism Mitochondria/metabolism Models, Biological Nerve Degeneration/metabolism,pathology Neurodegenerative Diseases/metabolism,pathology
Chemicals
Iron-Regulatory Proteins Iron-Sulfur Proteins Adenosine Triphosphate Iron
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Horowitz Maxx P
Medical Scientist Training Program, University of Pittsburgh, Pittsburgh, PA, USA.
Greenamyre J Timothy
References (114)
114 references, click to expand
  1. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease.
    J Neural Transm Park Dis Dement Sect. 1992;4(1):27-34 PMID: 1347219
  2. Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia.
    Hum Mol Genet. 2008 Aug 1;17(15):2265-73 PMID: 18424449
  3. Iron, brain ageing and neurodegenerative disorders.
    Nat Rev Neurosci. 2004 Nov;5(11):863-73 PMID: 15496864
  4. The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element.
    Mol Psychiatry. 2007 Mar;12(3):222-3 PMID: 17325711
  5. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.
    Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2214-9 PMID: 10681454
  6. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis.
    Nature. 2005 Aug 18;436(7053):1035-39 PMID: 16110529
  7. Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway.
    Mol Biol Cell. 2007 Mar;18(3):743-54 PMID: 17182845
  8. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.
    J Biol Chem. 2002 Nov 22;277(47):45518-28 PMID: 12198135
  9. Original Papers: ON THE OCCURRENCE OF ABNORMAL DEPOSITS OF IRON IN THE BRAIN IN PARKINSONISM WITH SPECIAL REFERENCE TO ITS LOCALISATION.
    J Neurol Psychopathol. 1924 Nov;5(19):195-208 PMID: 21611545
  10. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
    FASEB J. 2009 Dec;23(12):4207-17 PMID: 19679638
  11. Overexpression of mitochondrial ferritin sensitizes cells to oxidative stress via an iron-mediated mechanism.
    Antioxid Redox Signal. 2009 Aug;11(8):1791-803 PMID: 19271990
  12. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells.
    Nat Genet. 2005 Nov;37(11):1264-9 PMID: 16227996
  13. Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications.
    Am J Physiol Cell Physiol. 2007 Oct;293(4):C1383-94 PMID: 17670894
  14. Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30.
    Neurotox Res. 2010 Jan;17(1):15-27 PMID: 19609632
  15. The role of iron in mitochondrial function.
    Biochim Biophys Acta. 2009 Jul;1790(7):629-36 PMID: 18948172
  16. In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.
    J Neural Transm (Vienna). 2006 Jun;113(6):775-80 PMID: 16755382
  17. Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration.
    Brain Res. 2007 Apr 6;1140:188-94 PMID: 16631136
  18. A high-throughput drug screen targeted to the 5'untranslated region of Alzheimer amyloid precursor protein mRNA.
    J Biomol Screen. 2006 Aug;11(5):469-80 PMID: 16928984
  19. Physical evidence that yeast frataxin is an iron storage protein.
    Biochemistry. 2002 May 28;41(21):6798-804 PMID: 12022884
  20. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria.
    Arch Biochem Biophys. 1977 Apr 30;180(2):248-57 PMID: 195520
  21. Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice.
    Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):12028-33 PMID: 18685102
  22. Cellular iron transport.
    Biochim Biophys Acta. 2009 May;1790(5):309-25 PMID: 19344751
  23. Intracellular kinetics of iron in reticulocytes: evidence for endosome involvement in iron targeting to mitochondria.
    Blood. 2005 Jan 1;105(1):368-75 PMID: 15331447
  24. Differences in the RNA binding sites of iron regulatory proteins and potential target diversity.
    Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4345-9 PMID: 8633068
  25. Diferric transferrin regulates transferrin receptor 2 protein stability.
    Blood. 2004 Dec 15;104(13):4287-93 PMID: 15319290
  26. Mitochondrial ferritin expression in adult mouse tissues.
    J Histochem Cytochem. 2007 Nov;55(11):1129-37 PMID: 17625226
  27. Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.
    Neurotox Res. 2006 Jan;9(1):1-13 PMID: 16464747
  28. A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease.
    Neurobiol Dis. 2009 Jun;34(3):417-31 PMID: 19250966
  29. Intracellular iron transport and storage: from molecular mechanisms to health implications.
    Antioxid Redox Signal. 2008 Jun;10(6):997-1030 PMID: 18327971
  30. Human ind1, an iron-sulfur cluster assembly factor for respiratory complex I.
    Mol Cell Biol. 2009 Nov;29(22):6059-73 PMID: 19752196
  31. Balancing acts: molecular control of mammalian iron metabolism.
    Cell. 2004 Apr 30;117(3):285-97 PMID: 15109490
  32. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network.
    Annu Rev Nutr. 2008;28:197-213 PMID: 18489257
  33. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease.
    J Alzheimers Dis. 2004 Jun;6(3):291-301 PMID: 15201484
  34. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2).
    Blood. 2005 Oct 1;106(7):2580-9 PMID: 15956281
  35. Crystal structure of human iron regulatory protein 1 as cytosolic aconitase.
    Structure. 2006 Jan;14(1):129-39 PMID: 16407072
  36. The relevance of iron in the pathogenesis of Parkinson's disease.
    Ann N Y Acad Sci. 2004 Mar;1012:193-208 PMID: 15105267
  37. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis.
    EMBO J. 2004 Jan 28;23(2):386-95 PMID: 14726953
  38. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
    Neuron. 2001 Jun;30(3):665-76 PMID: 11430801
  39. Iron-sulfur proteins in health and disease.
    Trends Endocrinol Metab. 2010 May;21(5):302-14 PMID: 20060739
  40. Alzheimer's disease.
    N Engl J Med. 2010 Jan 28;362(4):329-44 PMID: 20107219
  41. Iron metabolism in Parkinsonian syndromes.
    Mov Disord. 2006 Sep;21(9):1299-310 PMID: 16817199
  42. Individual dopaminergic neurons show raised iron levels in Parkinson disease.
    Neurology. 2007 May 22;68(21):1820-5 PMID: 17515544
  43. Biosynthesis of heme in mammals.
    Biochim Biophys Acta. 2006 Jul;1763(7):723-36 PMID: 16839620
  44. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.
    Arch Neurol. 2003 Dec;60(12):1685-91 PMID: 14676042
  45. Copper, iron and zinc in Alzheimer's disease senile plaques.
    J Neurol Sci. 1998 Jun 11;158(1):47-52 PMID: 9667777
  46. Iron misregulation in the brain: a primary cause of neurodegenerative disorders.
    Lancet Neurol. 2003 Apr;2(4):246-53 PMID: 12849213
  47. Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators.
    BMC Neurosci. 2008 Dec 03;9 Suppl 2:S2 PMID: 19090990
  48. Mitoferrin is essential for erythroid iron assimilation.
    Nature. 2006 Mar 2;440(7080):96-100 PMID: 16511496
  49. An oxidative stress-mediated positive-feedback iron uptake loop in neuronal cells.
    J Neurochem. 2002 Jul;82(2):240-8 PMID: 12124425
  50. A human mitochondrial ferritin encoded by an intronless gene.
    J Biol Chem. 2001 Jul 6;276(27):24437-40 PMID: 11323407
  51. Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2.
    Mol Cell Biol. 2009 Feb;29(4):1007-16 PMID: 19075006
  52. Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease.
    Antioxid Redox Signal. 2010 Sep 15;13(6):783-96 PMID: 20121342
  53. In vitro studies of ferritin iron release and neurotoxicity.
    J Neurochem. 1998 Jun;70(6):2492-9 PMID: 9603214
  54. The 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesis.
    Nat Struct Biol. 2001 Feb;8(2):156-60 PMID: 11175906
  55. Role of rasagiline in treating Parkinson's disease: Effect on disease progression.
    Ther Clin Risk Manag. 2009 Aug;5(4):413-9 PMID: 19753135
  56. Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.
    J Neurochem. 2003 Sep;86(5):1142-8 PMID: 12911622
  57. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis.
    Science. 2009 Oct 30;326(5953):722-6 PMID: 19762597
  58. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.
    Neuron. 2008 Jul 10;59(1):43-55 PMID: 18614028
  59. Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases.
    Annu Rev Biochem. 2008;77:669-700 PMID: 18366324
  60. Abcb10 physically interacts with mitoferrin-1 (Slc25a37) to enhance its stability and function in the erythroid mitochondria.
    Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16263-8 PMID: 19805291
  61. nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse.
    Blood. 2005 Nov 15;106(10):3625-31 PMID: 15994289
  62. Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier.
    Brain Res. 2004 Mar 19;1001(1-2):108-17 PMID: 14972659
  63. Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group.
    Ann Neurol. 1992 Dec;32(6):782-8 PMID: 1471869
  64. Role of hepcidin in murine brain iron metabolism.
    Cell Mol Life Sci. 2010 Jan;67(1):123-33 PMID: 19898775
  65. Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats.
    Neuropharmacology. 2004 Feb;46(2):254-63 PMID: 14680763
  66. Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease.
    J Neurochem. 2002 Sep;82(5):1137-47 PMID: 12358761
  67. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.
    J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):144-51 PMID: 16706826
  68. Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron.
    Biochemistry. 2007 Nov 6;46(44):12737-43 PMID: 17929832
  69. Structure of dual function iron regulatory protein 1 complexed with ferritin IRE-RNA.
    Science. 2006 Dec 22;314(5807):1903-8 PMID: 17185597
  70. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18578-83 PMID: 19011085
  71. The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron-sulfur cluster biogenesis.
    Hum Mol Genet. 2006 Mar 15;15(6):953-64 PMID: 16467350
  72. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1.
    Nat Cell Biol. 2009 Jun;11(6):747-52 PMID: 19448625
  73. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.
    Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9866-8 PMID: 9275217
  74. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen.
    Biochem J. 1973 Jul;134(3):707-16 PMID: 4749271
  75. Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease.
    J Neurochem. 2007 Jan;100(2):490-502 PMID: 17144902
  76. RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload.
    Blood. 2007 Apr 15;109(8):3552-9 PMID: 17192393
  77. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.
    Blood. 2003 Mar 1;101(5):1996-2000 PMID: 12406866
  78. Iron-sulfur cluster biogenesis and human disease.
    Trends Genet. 2008 Aug;24(8):398-407 PMID: 18606475
  79. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice.
    Nat Genet. 2001 Feb;27(2):209-14 PMID: 11175792
  80. Assay of metabolic superoxide production in Escherichia coli.
    J Biol Chem. 1991 Apr 15;266(11):6957-65 PMID: 1849898
  81. Intramuscular desferrioxamine in patients with Alzheimer's disease.
    Lancet. 1991 Jun 1;337(8753):1304-8 PMID: 1674295
  82. The power plant of the cell is also a smithy: the emerging role of mitochondria in cellular iron homeostasis.
    Ann Med. 2009;41(2):82-99 PMID: 18720092
  83. The effect of age on the non-haemin iron in the human brain.
    J Neurochem. 1958 Oct;3(1):41-51 PMID: 13611557
  84. Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis.
    Tohoku J Exp Med. 2007 Sep;213(1):1-16 PMID: 17785948
  85. Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis.
    Blood. 2005 Mar 1;105(5):2161-7 PMID: 15522954
  86. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload.
    Blood. 2007 Aug 15;110(4):1353-8 PMID: 17485548
  87. The iron-sulphur protein Ind1 is required for effective complex I assembly.
    EMBO J. 2008 Jun 18;27(12):1736-46 PMID: 18497740
  88. Distribution of the iron-regulating protein hepcidin in the murine central nervous system.
    J Neurosci Res. 2006 Sep;84(4):790-800 PMID: 16933319
  89. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.
    Neuron. 2003 Mar 27;37(6):899-909 PMID: 12670420
  90. Control of iron homeostasis by an iron-regulated ubiquitin ligase.
    Science. 2009 Oct 30;326(5953):718-21 PMID: 19762596
  91. Direct interorganellar transfer of iron from endosome to mitochondrion.
    Blood. 2007 Jul 1;110(1):125-32 PMID: 17376890
  92. Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia.
    Hum Mol Genet. 2009 Jan 1;18(1):1-11 PMID: 18815198
  93. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease.
    J Neurosci Res. 1992 Feb;31(2):327-35 PMID: 1573683
  94. Metal-responsive transcription factors that regulate iron, zinc, and copper homeostasis in eukaryotic cells.
    Eukaryot Cell. 2004 Feb;3(1):1-13 PMID: 14871932
  95. Alzheimer's disease, metal ions and metal homeostatic therapy.
    Trends Pharmacol Sci. 2009 Jul;30(7):346-55 PMID: 19540003
  96. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
    J Neurochem. 2006 Apr;97(2):527-36 PMID: 16539659
  97. Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones.
    Hum Mol Genet. 2007 Apr 15;16(8):929-41 PMID: 17331979
  98. Characterization and expression of iron regulatory protein 2 (IRP2). Presence of multiple IRP2 transcripts regulated by intracellular iron levels.
    J Biol Chem. 1995 Jul 14;270(28):16529-35 PMID: 7622457
  99. M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease.
    J Neural Transm Suppl. 2006;(70):447-56 PMID: 17017567
  100. Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis.
    J Neurochem. 1992 Sep;59(3):1168-71 PMID: 1494904
  101. Human ferrochelatase is an iron-sulfur protein.
    Biochemistry. 1994 Jan 18;33(2):403-7 PMID: 8286370
  102. Iron as a cause of Parkinson disease - a myth or a well established hypothesis?
    Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S212-4 PMID: 20082993
  103. Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease.
    Brain Res. 2009 Nov 10;1297:17-22 PMID: 19699718
  104. Iron-induced oligomerization of yeast frataxin homologue Yfh1 is dispensable in vivo.
    EMBO Rep. 2004 Nov;5(11):1096-101 PMID: 15472712
  105. How iron controls iron.
    Cell Metab. 2009 Dec;10(6):439-41 PMID: 19945401
  106. Labile iron pool: the main determinant of cellular response to oxidative stress.
    Mutat Res. 2003 Oct 29;531(1-2):81-92 PMID: 14637247
  107. Discovery of genes essential for heme biosynthesis through large-scale gene expression analysis.
    Cell Metab. 2009 Aug;10(2):119-30 PMID: 19656490
  108. The heme synthesis defect of mutants impaired in mitochondrial iron-sulfur protein biogenesis is caused by reversible inhibition of ferrochelatase.
    J Biol Chem. 2004 Jul 9;279(28):29101-8 PMID: 15128732
  109. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
    J Neurochem. 2007 Oct;103(1):17-37 PMID: 17623039
  110. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo.
    Science. 2004 Dec 17;306(5704):2087-90 PMID: 15604406
  111. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.
    J Alzheimers Dis. 2009;16(4):879-95 PMID: 19387120
  112. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain.
    Neuroscience. 1996 Jul;73(2):407-15 PMID: 8783258
  113. Identification of a mammalian mitochondrial porphyrin transporter.
    Nature. 2006 Oct 5;443(7111):586-9 PMID: 17006453
  114. Oligodendrogenesis: the role of iron.
    Biofactors. 2010 Mar-Apr;36(2):98-102 PMID: 20336710
Article Info
Journal
Journal of Alzheimer's disease : JAD
Abbr.
J Alzheimers Dis
ISSN
1875-8908
Published
2010-00-00
Pages
S551-68
Language
English
Region
Netherlands
NLM ID
9814863
PMCID
PMC3085540
Subset
IM
Grants
NINDS NIH HHS · P01 NS059806 · United States
NINDS NIH HHS · P01 NS059806-02 · United States
NINDS NIH HHS · 1P02NS059806 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com